TAC1 and Alzheimer disease: Thus, based on the known effect of Douchi, we explored to determine whether Douchi alleviates clinical AD symptoms through regulating further expanding inflammatory factors including mast cells, substance P, iNOS and MMP-9 as well as PKC and IL-4.